The Custom Pharmaceutical Services (CPS) business of Dr. Reddy’s Laboratories has expanded operations at its facility in Mirfield, UK in the areas of activated mPEG manufacturing and the development and manufacture of NCE APIs for preclinical through to commercial development.   The expansion enables the manufacture of its PEGtech range at commercial metric ton scale quantities in a cGMP environment. Dr. Reddy’s has eight API manufacturing facilities, six FDA-approved plants in India, one FDA-ap...